A Clinical Trial Evaluating the Safety of TD001 In Patients With PSMA-Expressing Metastatic Prostate Cancer
A Clinical Trial Evaluating the Safety of TD001 In Patients With PSMA-Expressing Metastatic Prostate Cancer
Recruiting · NCT07258407 · Registry updated 2026-05-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Trial Evaluating the Safety of TD001 In Patients With PSMA-Expressing Metastatic Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Prostatic Neoplasms, Castration-Resistant, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 1 / Phase 2 | 2026-05-29 | NCT07258407 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| T.O.A.D. Oncology SA | 1 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hôpital Paris Saint Joseph | Paris | France | 7 |
| Institut Bergonié | Bordeaux | France | 53 |
| Institut Gustave Roussy | Villejuif | France | 113 |
| Peter MacCallum Cancer Centre | Melbourne | Australia | 149 |
| Princess Margaret Cancer Centre | Toronto | Canada | 145 |
| Vall d'Hebron Institute of Oncology | Barcelona | Spain | 9 |
| Yale University, Yale Cancer Center | New Haven | United States | 7 |